82_FR_13165 82 FR 13120 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

82 FR 13120 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 45 (March 9, 2017)

Page Range13120-13120
FR Document2017-04624

Federal Register, Volume 82 Issue 45 (Thursday, March 9, 2017)
[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13120]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04624]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
DP17-003, Natural Experiments of Policy and Built Environment Impact on 
Diabetes Risk.
    Times and Dates:

10:00 a.m.-6:00 p.m., EDT, April 12, 2017 (Closed)
10:00 a.m.-6:00 p.m., EDT, April 13, 2017 (Closed)


    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Natural Experiments of Policy and Built Environment Impact on 
Diabetes Risk'', FOA D P17-003.
    Contact Person for More Information: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04624 Filed 3-8-17; 8:45 am]
 BILLING CODE 4163-18-P



                                                    13120                         Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices

                                                    DEPARTMENT OF HEALTH AND                                accommodates approximately 60                           Times and Dates:
                                                    HUMAN SERVICES                                          people. Advance registration for in-                  10:00 a.m.–6:00 p.m., EDT, April 12,
                                                                                                            person participation is required by April               2017 (Closed)
                                                    Centers for Disease Control and                         5, 2017. The public is welcome to                     10:00 a.m.–6:00 p.m., EDT, April 13,
                                                    Prevention                                              participate during the public comment                   2017 (Closed)
                                                                                                            period, which is tentatively scheduled
                                                    Advisory Council for the Elimination of                 from 3:45 p.m. to 3:55 p.m. This                         Place: Teleconference.
                                                    Tuberculosis: Notice of Charter                         meeting will also be available by                        Status: The meeting will be closed to
                                                    Renewal                                                 teleconference. Please dial (866) 918–                the public in accordance with
                                                                                                            8397 and enter code 9346283.                          provisions set forth in Section 552b(c)
                                                       This gives notice under the Federal                                                                        (4) and (6), Title 5 U.S.C., and the
                                                    Advisory Committee Act (Pub. L. 92–                        Purpose: The Subcommittee will
                                                                                                            provide advice to the CDC Director                    Determination of the Director,
                                                    463) of October 6, 1972, that the                                                                             Management Analysis and Services
                                                    Advisory Council for the Elimination of                 through the ACD on strategic and other
                                                                                                            health disparities and health equity                  Office, CDC, pursuant to Public Law 92–
                                                    Tuberculosis, Department of Health and                                                                        463.
                                                    Human Services, has been renewed for                    issues and provide guidance on
                                                                                                            opportunities for CDC.                                   Matters for Discussion: The meeting
                                                    a 2-year period through March 15, 2019.                                                                       will include the initial review,
                                                       For information, contact Hazel Dean,                    Matters for Discussion: The Health
                                                                                                            Disparities Subcommittee members will                 discussion, and evaluation of
                                                    Sc.D., M.P.H., Designated Federal
                                                                                                            receive an update on selected                         applications received in response to
                                                    Officer, Advisory Council for the
                                                                                                            recommendations of the HDS, and on                    ‘‘Natural Experiments of Policy and
                                                    Elimination of Tuberculosis,
                                                                                                            progress toward Health Equity and                     Built Environment Impact on Diabetes
                                                    Department of Health and Human
                                                                                                            Public Health Accreditation.                          Risk’’, FOA D P17–003.
                                                    Services, 1600 Clifton Road NE.,
                                                                                                               Agenda items are subject to change as                 Contact Person for More Information:
                                                    Mailstop E–10, Atlanta, Georgia 30333,
                                                                                                            priorities dictate.                                   Jaya Raman Ph.D., Scientific Review
                                                    telephone 404/639–8000 or fax 404/
                                                                                                               Contact Person for More Information:               Officer, CDC, 4770 Buford Highway,
                                                    639–8600.
                                                       The Director, Management Analysis                    Leandris Liburd, Ph.D., M.P.H., M.A.,                 Mailstop F80, Atlanta, Georgia 30341,
                                                    and Services Office, has been delegated                 Designated Federal Officer, Health                    Telephone: (770) 488–6511, kva5@
                                                    the authority to sign Federal Register                  Disparities Subcommittee, Advisory                    cdc.gov.
                                                    notices pertaining to announcements of                  Committee to the Director, CDC, 1600                     The Director, Management Analysis
                                                    meetings and other committee                            Clifton Road NE., M/S K–77, Atlanta,                  and Services Office, has been delegated
                                                    management activities, for both the                     Georgia 30329. Telephone (404) 498–                   the authority to sign Federal Register
                                                    Centers for Disease Control and                         6482, Email: ACDirector@cdc.gov.                      notices pertaining to announcements of
                                                    Prevention and the Agency for Toxic                        The Director, Management Analysis                  meetings and other committee
                                                    Substances and Disease Registry.                        and Services Office, has been delegated               management activities, for both the
                                                                                                            the authority to sign Federal Register                Centers for Disease Control and
                                                    Elaine L. Baker,                                        notices pertaining to announcements of                Prevention and the Agency for Toxic
                                                    Director, Management Analysis and Services              meetings and other committee                          Substances and Disease Registry.
                                                    Office, Centers for Disease Control and                 management activities, for both the
                                                    Prevention.                                                                                                   Elaine L. Baker,
                                                                                                            Centers for Disease Control and
                                                    [FR Doc. 2017–04616 Filed 3–8–17; 8:45 am]                                                                    Director, Management Analysis and Services
                                                                                                            Prevention and the Agency for Toxic                   Office, Centers for Disease Control and
                                                    BILLING CODE 4163–18–P                                  Substances and Disease Registry.                      Prevention.
                                                                                                            Elain L. Baker,                                       [FR Doc. 2017–04624 Filed 3–8–17; 8:45 am]
                                                    DEPARTMENT OF HEALTH AND                                Director, Management Analysis and Services            BILLING CODE 4163–18–P
                                                    HUMAN SERVICES                                          Office, Centers for Disease Control and
                                                                                                            Prevention (CDC).
                                                    Centers for Disease Control and                         [FR Doc. 2017–04619 Filed 3–8–17; 8:45 am]            DEPARTMENT OF HEALTH AND
                                                    Prevention                                              BILLING CODE 4163–18–P                                HUMAN SERVICES

                                                    Advisory Committee to the Director                                                                            Centers for Disease Control and
                                                    (ACD), Centers for Disease Control and                  DEPARTMENT OF HEALTH AND                              Prevention
                                                    Prevention (CDC)—Health Disparities                     HUMAN SERVICES
                                                    Subcommittee (HDS)                                                                                            Disease, Disability, and Injury
                                                                                                            Centers for Disease Control and                       Prevention and Control Special
                                                      In accordance with section 10(a)(2) of                Prevention                                            Emphasis Panel (SEP): Initial Review
                                                    the Federal Advisory Committee Act
                                                    (Pub. L. 92–463), the Centers for Disease                                                                       In accordance with Section 10(a)(2) of
                                                                                                            Disease, Disability, and Injury
                                                    Control and Prevention (CDC)                                                                                  the Federal Advisory Committee Act
                                                                                                            Prevention and Control Special
                                                    announces the following meeting of the                                                                        (Pub. L. 92–463), the Centers for Disease
                                                                                                            Emphasis Panel (SEP): Initial Review
                                                    aforementioned committee:                                                                                     Control and Prevention (CDC)
                                                      Time and Date: 8:30 p.m.–4:00 p.m.,                     In accordance with Section 10(a)(2) of              announces a meeting for the initial
                                                                                                            the Federal Advisory Committee Act                    review of applications in response to
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    EDT, April 19, 2017.
                                                      Place: Centers for Disease Control &                  (Pub. L. 92–463), the Centers for Disease             Funding Opportunity Announcement
                                                    Prevention (CDC), Global                                Control and Prevention (CDC)                          (FOA) DP17–002, Validation of Survey
                                                    Communications Center, Building 19,                     announces a meeting for the initial                   Questions to Distinguish Type 1 and
                                                    Rooms 254/255, 1600 Clifton Road NE.,                   review of applications in response to                 Type 2 Diabetes among Adults with
                                                    Atlanta, Georgia 30329.                                 Funding Opportunity Announcement                      Diabetes.
                                                      Status: Open to the public, limited                   (FOA) DP17–003, Natural Experiments                     Time and Date: 10:00 a.m.–6:00 p.m.,
                                                    only by the space and phone lines                       of Policy and Built Environment Impact                EDT, April 5, 2017 (Closed).
                                                    available. The meeting room                             on Diabetes Risk.                                       Place: Teleconference.


                                               VerDate Sep<11>2014   17:43 Mar 08, 2017   Jkt 241001   PO 00000   Frm 00032   Fmt 4703   Sfmt 4703   E:\FR\FM\09MRN1.SGM   09MRN1



Document Created: 2017-03-09 04:59:19
Document Modified: 2017-03-09 04:59:19
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation82 FR 13120 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR